Literature DB >> 12726849

Screening procedure for eight quaternary nitrogen muscle relaxants in blood by high-performance liquid chromatography-electrospray ionization mass spectrometry.

V Cirimele1, M Villain, G Pépin, B Ludes, P Kintz.   

Abstract

A screening procedure was developed for the identification and the quantification of eight quaternary nitrogen muscle relaxants, including d-tubocurarine, alcuronium, pancuronium, vecuronium, atracurium, mivacurium, rocuronium and mebezonium, in blood samples. The procedure involves ion-pair extraction with methylene chloride at pH 5.4, reversed-phase HPLC separation and electrospray ionization mass spectrometry detection. The procedure was validated in terms of linearity (0.929<r<0.998 for concentrations ranging from 0.1 to 10 mg/l), repeatability (6.9<RSD<17.8% at 1 mg/l, n=8), relative extraction recovery (46.0 to 91.1% at 1 mg/l, n=8) and limit of detection (S/N ratio >5 for all the target compounds at 0.1 mg/l). The screening test was found satisfactory and applied in two fatal deaths. In the first case, toxicological investigations on biological fluids collected during the autopsy revealed the presence of vecuronium (1.2 and 0.6 mg/l in blood and urine, respectively) and its desacetylated metabolite, 3-hydroxy-vecuronium (4.4 and 0.7 mg vecuronium equivalent/l in blood and urine, respectively). In the second forensic case, blood analysis showed high levels of mebezonium (6.5 mg/l). The developed procedure was found suitable for forensic investigations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726849     DOI: 10.1016/s1570-0232(03)00070-9

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument.

Authors:  Kevin D Ballard; William E Vickery; Loan T Nguyen; Francis X Diamond; Fredric Rieders
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-02       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.